$CDZI
CADIZ INC

2022 Q3 Form 10-Q Financial Statement

#000143774922020254 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $599.0K $185.0K $142.0K
YoY Change 321.83% 31.21% 2.16%
Cost Of Revenue $1.163M $0.00
YoY Change
Gross Profit -$564.0K $185.0K
YoY Change -497.18%
Gross Profit Margin -94.16% 100.0%
Selling, General & Admin $3.770M $3.405M $3.806M
YoY Change -10.28% -46.59% 17.83%
% of Gross Profit 1840.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $180.0K $172.0K $121.0K
YoY Change 68.22% 62.26% 17.48%
% of Gross Profit 92.97%
Operating Expenses $3.880M $3.577M $3.927M
YoY Change -9.96% -44.78% 17.57%
Operating Profit -$4.444M -$3.392M -$3.785M
YoY Change 6.65% -46.47% 18.39%
Interest Expense $2.097M $2.055M $1.991M
YoY Change 4.85% -57.7% -21.68%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.541M -$5.447M -$5.776M
YoY Change -13.55% -51.34% 0.64%
Income Tax $2.000K $1.000K $2.000K
% Of Pretax Income
Net Earnings -$6.545M -$5.483M -$5.912M
YoY Change -16.51% -52.58% -0.54%
Net Earnings / Revenue -1092.65% -2963.78% -4163.38%
Basic Earnings Per Share -$0.15 -$0.13 -$0.16
Diluted Earnings Per Share -$128.9K -$108.0K -$133.1K
COMMON SHARES
Basic Shares Outstanding 50.79M 50.77M 44.43M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.957M $13.24M $18.82M
YoY Change -62.55% 18.35% 0.64%
Cash & Equivalents $6.957M $13.24M $18.82M
Short-Term Investments
Other Short-Term Assets $2.079M $2.198M $2.058M
YoY Change -4.89% 77.98% 157.25%
Inventory $335.0K
Prepaid Expenses
Receivables $546.0K $154.0K $124.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.917M $15.59M $21.00M
YoY Change -52.42% 24.86% 7.66%
LONG-TERM ASSETS
Property, Plant & Equipment $80.77M $80.51M $79.38M
YoY Change 4.11% 5.8% 47.81%
Goodwill $3.813M $3.813M $3.813M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $906.0K $907.0K $942.0K
YoY Change -4.53% -13.12% -26.86%
Other Assets $4.510M $4.538M $4.567M
YoY Change 4.3% 1.14% -7.48%
Total Long-Term Assets $94.21M $98.51M $98.74M
YoY Change -5.1% 10.49% 40.97%
TOTAL ASSETS
Total Short-Term Assets $9.917M $15.59M $21.00M
Total Long-Term Assets $94.21M $98.51M $98.74M
Total Assets $104.1M $114.1M $119.7M
YoY Change -13.31% 12.25% 33.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $462.0K $633.0K $1.095M
YoY Change -20.21% 441.03% 518.64%
Accrued Expenses $907.0K $1.582M $1.539M
YoY Change -63.44% -26.62% -25.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $148.0K $57.00K $82.00K
YoY Change 10.45% 32.56% 74.47%
Total Short-Term Liabilities $2.782M $3.586M $4.006M
YoY Change -40.39% 53.18% 72.97%
LONG-TERM LIABILITIES
Long-Term Debt $48.35M $47.61M $47.03M
YoY Change 5.28% -42.28% -40.41%
Other Long-Term Liabilities $35.00K $34.00K $33.00K
YoY Change 12.9% 9.68% -99.85%
Total Long-Term Liabilities $48.39M $47.64M $47.06M
YoY Change 5.28% -42.26% -40.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.782M $3.586M $4.006M
Total Long-Term Liabilities $48.39M $47.64M $47.06M
Total Liabilities $72.18M $74.84M $74.13M
YoY Change -1.1% -29.87% -27.75%
SHAREHOLDERS EQUITY
Retained Earnings -$595.2M -$587.3M -$580.6M
YoY Change 5.11% 5.46% 6.46%
Common Stock $506.0K $506.0K $506.0K
YoY Change 19.34% 24.94% 32.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.94M $39.26M $45.61M
YoY Change
Total Liabilities & Shareholders Equity $104.1M $114.1M $119.7M
YoY Change -13.31% 12.25% 33.71%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.545M -$5.483M -$5.912M
YoY Change -16.51% -52.58% -0.54%
Depreciation, Depletion And Amortization $180.0K $172.0K $121.0K
YoY Change 68.22% 62.26% 17.48%
Cash From Operating Activities -$5.824M -$4.328M -$3.200M
YoY Change 59.82% 36.14% 13.35%
INVESTING ACTIVITIES
Capital Expenditures -$684.0K -$1.218M $530.0K
YoY Change -25.41% -93.81% 3.31%
Acquisitions
YoY Change
Other Investing Activities -$1.000K $0.00 -$100.0K
YoY Change -99.43% -100.0% -28.57%
Cash From Investing Activities -$685.0K -$1.218M -$630.0K
YoY Change -37.33% -93.84% -3.08%
FINANCING ACTIVITIES
Cash Dividend Paid $1.288M
YoY Change
Common Stock Issuance & Retirement, Net $11.74M
YoY Change -21.03%
Debt Paid & Issued, Net $35.00K
YoY Change 169.23%
Cash From Financing Activities -1.061M -1.299M $10.42M
YoY Change -104.75% -108.39% -29.86%
NET CHANGE
Cash From Operating Activities -5.824M -4.328M -$3.200M
Cash From Investing Activities -685.0K -1.218M -$630.0K
Cash From Financing Activities -1.061M -1.299M $10.42M
Net Change In Cash -7.570M -6.845M $6.566M
YoY Change -143.02% -8.54% -42.31%
FREE CASH FLOW
Cash From Operating Activities -$5.824M -$4.328M -$3.200M
Capital Expenditures -$684.0K -$1.218M $530.0K
Free Cash Flow -$5.140M -$3.110M -$3.730M
YoY Change 88.49% -118.86% 11.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50770275
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50770275
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43656169
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43656169
CY2022Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2022Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
560
CY2022Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2013Q1 cdzi Number Of Milestones For Common Stock Issuance
NumberOfMilestonesForCommonStockIssuance
2 pure
CY2013Q1 cdzi Shares Payable Term From Date Earned
SharesPayableTermFromDateEarned
P3Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-12114
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0313235
dei Entity Address Address Line1
EntityAddressAddressLine1
550 South Hope Street, Suite 2850
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90071
dei City Area Code
CityAreaCode
213
dei Local Phone Number
LocalPhoneNumber
271-1600
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50793567
CY2022Q2 us-gaap Revenues
Revenues
185000 usd
CY2021Q2 us-gaap Revenues
Revenues
141000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3405000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6375000 usd
CY2022Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
172000 usd
CY2021Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
103000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
3577000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
6478000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3392000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6337000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
2055000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
4858000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5447000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11195000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35000 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-366000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5483000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11562000 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1288000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3281000 usd
CY2021Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6771000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11562000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50770000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39099000
us-gaap Revenues
Revenues
328000 usd
us-gaap Revenues
Revenues
280000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7211000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9608000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
293000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
206000 usd
us-gaap Costs And Expenses
CostsAndExpenses
7504000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9814000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7176 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9534 usd
us-gaap Interest Expense
InterestExpense
4047000 usd
us-gaap Interest Expense
InterestExpense
7400000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11223000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16934000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-169000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-569000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11395000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17506000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2553000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13948000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17506000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47619000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38470000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13239000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10965000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
270000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
910000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
691000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
15591000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13214000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80509000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78890000 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 usd
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
907000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
976000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
3813000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
3813000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3269000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5050000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7603000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4538000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4296000 usd
CY2022Q2 us-gaap Assets
Assets
114097000 usd
CY2021Q4 us-gaap Assets
Assets
112493000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
633000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
286000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1582000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
808000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
57000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
107000 usd
CY2022Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
1288000 usd
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1288000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3586000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2513000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
47606000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46477000 usd
CY2022Q2 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
19780000 usd
CY2021Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
18855000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3083000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3257000 usd
CY2022Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
34000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
74839000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
71884000 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
506000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
436000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
626098000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
613572000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-587348000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-573400000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39258000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40609000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114097000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112493000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11395000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17506000 usd
us-gaap Depreciation
Depreciation
293000 usd
us-gaap Depreciation
Depreciation
206000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1160000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2372000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15000 usd
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
0 usd
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
4209000 usd
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
913000 usd
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
806000 usd
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-169000 usd
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-569000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
856000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3440000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-116000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
219000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
544000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
242000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-177000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
216000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-154000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-172000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-175000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
743000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1170000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7550000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5999000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1748000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20177000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
100000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
259000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1848000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20436000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11741000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30354000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2553000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
-0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
69000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9119000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30331000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-279000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3896000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19856000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19577000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11320000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40609000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
433000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11741000 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5912000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
45606000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
423000 usd
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1288000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5483000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39258000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 usd
CY2021Q1 cdzi Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability
3179000 usd
us-gaap Depreciation
Depreciation
293000 usd
us-gaap Depreciation
Depreciation
206000 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
148000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5944000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-13052000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3293000 usd
CY2021Q2 cdzi Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
4000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-11562000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5065.000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11400000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17500000 usd
CY2022Q2 cdzi Working Capital
WorkingCapital
12000000.0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7600000 usd
CY2021Q3 cdzi Deposits Segregated Account Prefund Eight Quarterly Dividend Payments
DepositsSegregatedAccountPrefundEightQuarterlyDividendPayments
10200000 usd
us-gaap Interest Paid Net
InterestPaidNet
1760000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13239000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10965000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11186000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5050000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7603000 usd
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19577000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19856000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11320000 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50770275
CY2013Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
400000
CY2021Q3 cdzi Deposits Segregated Account Prefund Eight Quarterly Dividend Payments
DepositsSegregatedAccountPrefundEightQuarterlyDividendPayments
10200000 usd
CY2021Q2 cdzi Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer
WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer
9500 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
856000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3440000
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
900000 usd
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1533000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3196000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1533000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2903000
CY2013Q1 cdzi Percentage Of Projects Annual Capacity
PercentageOfProjectsAnnualCapacity
0.51 pure
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
4002000 usd

Files In Submission

Name View Source Status
0001437749-22-020254-index-headers.html Edgar Link pending
0001437749-22-020254-index.html Edgar Link pending
0001437749-22-020254.txt Edgar Link pending
0001437749-22-020254-xbrl.zip Edgar Link pending
cdzi-20220630.xsd Edgar Link pending
cdzi20220630_10q.htm Edgar Link pending
ex_410732.htm Edgar Link pending
ex_410738.htm Edgar Link pending
ex_410767.htm Edgar Link pending
ex_410768.htm Edgar Link pending
ex_410769.htm Edgar Link pending
ex_410770.htm Edgar Link pending
ex_410771.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image1.jpg Edgar Link pending
image10.jpg Edgar Link pending
image11.jpg Edgar Link pending
image12.jpg Edgar Link pending
image13.jpg Edgar Link pending
image14.jpg Edgar Link pending
image15.jpg Edgar Link pending
image2.jpg Edgar Link pending
image3.jpg Edgar Link pending
image4.jpg Edgar Link pending
image5.jpg Edgar Link pending
image6.jpg Edgar Link pending
image7.jpg Edgar Link pending
image8.jpg Edgar Link pending
image9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
cdzi-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cdzi-20220630_lab.xml Edgar Link unprocessable
cdzi-20220630_pre.xml Edgar Link unprocessable
cdzi20220630_10q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cdzi-20220630_def.xml Edgar Link unprocessable